Latest period
$45.88B
YoY change
+13.6%
5Y CAGR
+15.8%
Peak year (2009)
$59.06B
Latest annual
$52.61B
Total Equity history chart for Merck & Co. (MRK) from 1985 to 2025
Latest: $52.61B
Total Equity growth chart for Merck & Co. (MRK) from 1985 to 2025
Latest: +13.6%
Total Equity history table for Merck & Co. (MRK) from 1985 to 2025
| 2025 | $52.61B | +13.6% | +$6.29B | ||
| 2024 | $46.31B | +23.2% | +$8.73B | ||
| 2023 | $37.58B | -18.3% | −$8.41B | ||
| 2022 | $45.99B | +20.4% | +$7.81B | ||
| 2021 | $38.18B | +50.8% | +$12.87B | ||
| 2020 | $25.32B | -2.3% | −$590.00M | ||
| 2019 | $25.91B | -3.0% | −$794.00M | ||
| 2018 | $26.70B | -22.2% | −$7.63B | ||
| 2017 | $34.34B | -14.3% | −$5.75B | ||
| 2016 | $40.09B | -10.3% | −$4.59B | ||
| 2015 | $44.68B | -8.2% | −$3.97B | ||
| 2014 | $48.65B | -2.2% | −$1.12B | ||
| 2013 | $49.77B | -6.1% | −$3.25B | ||
| 2012 | $53.02B | -2.7% | −$1.50B | ||
| 2011 | $54.52B | +0.3% | +$141.00M | ||
| 2010 | $54.38B | -7.9% | −$4.68B | ||
| 2009 | $59.06B | +214.8% | +$40.30B | ||
| 2008 | $18.76B | +3.2% | +$573.60M | ||
| 2007 | $18.18B | +3.6% | +$625.00M | ||
| 2006 | $17.56B | -2.3% | −$418.00M | ||
| 2005 | $17.98B | +4.0% | +$689.50M | ||
| 2004 | $17.29B | +11.0% | +$1.71B | ||
| 2003 | $15.58B | -14.4% | −$2.62B | ||
| 2002 | $18.20B | +13.4% | +$2.15B | ||
| 2001 | $16.05B | +8.2% | +$1.22B | ||
| 2000 | $14.83B | +12.0% | +$1.59B | ||
| 1999 | $13.24B | +3.4% | +$439.80M | ||
| 1998 | $12.80B | +1.6% | +$207.20M | ||
| 1997 | $12.59B | +5.2% | +$624.10M | ||
| 1996 | $11.97B | +2.0% | +$234.80M | ||
| 1995 | $11.74B | +5.4% | +$596.70M | ||
| 1994 | $11.14B | +11.1% | +$1.12B | ||
| 1993 | $10.02B | +100.3% | +$5.02B | ||
| 1992 | $5.00B | +1.8% | +$86.70M | ||
| 1991 | $4.92B | +28.2% | +$1.08B | ||
| 1990 | $3.83B | +8.9% | +$313.80M | ||
| 1989 | $3.52B | +23.3% | +$664.80M | ||
| 1988 | $2.86B | +34.9% | +$739.10M | ||
| 1987 | $2.12B | -17.6% | −$452.40M | ||
| 1986 | $2.57B | -2.5% | −$64.90M | ||
| 1985 | $2.63B | — | — |
- 2025$52.61B+13.6%
- 2024$46.31B+23.2%
- 2023$37.58B-18.3%
- 2022$45.99B+20.4%
- 2021$38.18B+50.8%
- 2020$25.32B-2.3%
- 2019$25.91B-3.0%
- 2018$26.70B-22.2%
- 2017$34.34B-14.3%
- 2016$40.09B-10.3%
- 2015$44.68B-8.2%
- 2014$48.65B-2.2%
- 2013$49.77B-6.1%
- 2012$53.02B-2.7%
- 2011$54.52B+0.3%
- 2010$54.38B-7.9%
- 2009$59.06B+214.8%
- 2008$18.76B+3.2%
- 2007$18.18B+3.6%
- 2006$17.56B-2.3%
- 2005$17.98B+4.0%
- 2004$17.29B+11.0%
- 2003$15.58B-14.4%
- 2002$18.20B+13.4%
- 2001$16.05B+8.2%
- 2000$14.83B+12.0%
- 1999$13.24B+3.4%
- 1998$12.80B+1.6%
- 1997$12.59B+5.2%
- 1996$11.97B+2.0%
- 1995$11.74B+5.4%
- 1994$11.14B+11.1%
- 1993$10.02B+100.3%
- 1992$5.00B+1.8%
- 1991$4.92B+28.2%
- 1990$3.83B+8.9%
- 1989$3.52B+23.3%
- 1988$2.86B+34.9%
- 1987$2.12B-17.6%
- 1986$2.57B-2.5%
- 1985$2.63B—
Total Equity values are taken from Merck & Co.'s reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Equity at Merck & Co. (MRK)
According to Merck & Co.'s latest reported financial statements, the company's latest reported total equity is $45.88B. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual total equity for Merck & Co. (MRK) came in at $52.61B – grew 13.6% year-over-year.
Through 2020–2025 (5 years), Merck & Co. total equity delivered a +15.8% annualised rate; sustaining 2 straight years of year-over-year growth.
Between 2009 and 2025, Merck & Co. total equity declined 10.9%, falling from $59.06B to $52.61B.
2009 marks the peak total equity at $59.06B, with the historical low of $2.12B recorded in 1987.
Merck & Co. Total Equity by Year
Merck & Co. Total Equity 2025: $52.61B
In 2025, Merck & Co. reported total equity of $52.61B, grew 13.6% from 2024.
Merck & Co. Total Equity 2024: $46.31B
Merck & Co. total equity in 2024 was $46.31B, grew 23.2% from 2023.
Merck & Co. Total Equity 2023: $37.58B
2023's total equity for Merck & Co. came in at $37.58B, declined 18.3% below 2022.
Merck & Co. Total Equity 2022: $45.99B
Merck & Co. posted total equity of $45.99B in 2022, grew 20.4% from 2021.
Merck & Co. Total Equity 2021: $38.18B
Merck & Co. total equity in 2021 was $38.18B.
See more financial history for Merck & Co. (MRK).
Sector peers by Total Equity
Healthcare peers of Merck & Co. (MRK), ranked by their latest total equity
| $94.11B | |
| $81.54B | |
| $53.41B | |
| $48.67B | |
| $30.52B | |
| $26.54B | |
| $8.66B | |
| −$3.27B |
- $94.11B
- $81.54B
- $48.67B
- $30.52B
- $26.54B
- $8.66B
- −$3.27B
Frequently asked questions
Merck & Co. (MRK) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation